Scott Sneddon

All filings by Scott Sneddon on record concern Sharp Therapeutics Corp. We count 3 filings; the first trade dates from 11 December 2024 and the latest from 26 August 2025.

Purchases make up the whole of the open-market record (2 purchases, €698). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. In 2025 alone, the filings show 2 purchases and no sales.

The newest entry dates from 9 September 2025: an open-market purchase of €652, in Sharp Therapeutics Corp. The median gap between a trade and its publication by SEDI is 14 days. The shorter that gap, the sooner other investors can see what insiders have done. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.